Omeros Corporation
OMER
#6443
Rank
S$0.99 B
Marketcap
S$14.06
Share price
-1.63%
Change (1 day)
-9.70%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2025 (TTM): -S$0.17 Billion

According to Omeros Corporation's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$0.21 Billion a decrease over its 2023 earnings that were of -S$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.17 Billion-18.77%
2024 -S$0.21 Billion9.63%
2023 -S$0.19 Billion-9.57%
2022 -S$0.21 Billion-30.65%
2021 -S$0.3 Billion86.28%
2020 -S$0.16 Billion99.45%
2019 -S$80.13 Million-49.91%
2018 -S$0.16 Billion190.77%
2017 -S$55.02 Million-27.96%
2016 -S$76.37 Million-17.61%
2015 -S$92.69 Million1.88%
2014 -S$90.98 Million87.56%
2013 -S$48.51 Million
2011 -S$35.53 Million-8.96%
2010 -S$39.02 Million45.03%
2009 -S$26.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-S$12.3 Million-92.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-S$5.01 Million-96.94%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Pfizer
PFE
S$15.35 B-9,490.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$41.98 B-25,768.33%๐Ÿ‡บ๐Ÿ‡ธ USA